Skip to main content
Clinical Trials/CTRI/2024/04/066506
CTRI/2024/04/066506
Not yet recruiting
未知

Predictive Clinical Features and Molecular Markers for tumor response and treatment Outcomes in HPV negative Oral Cancers - NI

Tata Memorial Centre0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Tata Memorial Centre
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • Individuals who are 18 years of age or above
  • \-Treatment naïve patients
  • \-Locally advanced Oral cancer patients
  • \-Those planned for Neoadjuvant Chemotherapy (NACT) as per the Joint Clinic decision will be included.

Exclusion Criteria

  • \-Subjects failing these criteria will be excluded from the study
  • \-Patients where the biopsy will not be possible at the time of inclusion in study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Study for biomarkers and molecular pathophysiology of Myeloproliferative disorders with eosinophilia.Hypereosinophilic syndrome, chronic eosinophilic leukemia, idiopathic eosinophilia.
JPRN-UMIN000009140Kobe University Medical School Hospital300
Recruiting
Not Applicable
Study for biomarkers and molecular pathophysiology of depression diversityMajor depressive disorder
JPRN-UMIN000007825Gunma University Graduate School of Medicine80
Recruiting
Not Applicable
Molecular markers for diagnosis and therapy response in Inflammatory Bowel diseases: A prospective population based bio-bank of inflammatory bowel disease patients in Zuid Limburg, The Netherlands.inflammatory bowel disease10017969
NL-OMON50587Interne geneeskunde/Divisie MD5,000
Recruiting
Not Applicable
Clinical, molecular and functional biomarkers for PROgnosis, pathomechanisms and treatment strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)Coronavirus Disease 19 (COVID-19)U07.1J12J13J14J15J16J17J18COVID-19, virus identifiedViral pneumonia, not elsewhere classifiedPneumonia due to Streptococcus pneumoniaePneumonia due to Haemophilus influenzaeBacterial pneumonia, not elsewhere classifiedPneumonia due to other infectious organisms, not elsewhere classifiedPneumonia in diseases classified elsewherePneumonia, organism unspecified
DRKS00022871CAPNETZ STIFTUNG, Geschäftsstelle an der Medizinischen Hochschule Hannover400
Completed
Not Applicable
Clinical, molecular and functional biomarkers for PROgnosis, pathomechanisms and treatment strategies of COVID-19 (PROVID) - (PROVID-PROGRESS)U07.1J12J13J14J15J16J17J18COVID-19, virus identifiedViral pneumonia, not elsewhere classifiedPneumonia due to Streptococcus pneumoniaePneumonia due to Haemophilus influenzaeBacterial pneumonia, not elsewhere classifiedPneumonia due to other infectious organisms, not elsewhere classifiedPneumonia in diseases classified elsewherePneumonia, organism unspecified
DRKS00023277Charité – Universitätsmedizin Berlin, Med. Klinik m. S. Infektiologie und Pneumologie, und Arbeitsbereich Pulmonale Inflammation94